Eugene P. Kennedy - Net Worth and Insider Trading

Eugene P. Kennedy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eugene P. Kennedy owns 2 companies in total, including Lumos Pharma Inc (LUMO) , and Galera Therapeutics Inc (GRTX) .

Click here to see the complete history of Eugene P. Kennedy’s form 4 insider trades.

Insider Ownership Summary of Eugene P. Kennedy

Ticker Comapny Transaction Date Type of Owner
LUMO Lumos Pharma Inc 2017-11-13 Chief Medical Officer
GRTX Galera Therapeutics Inc 2022-09-01 Chief Medical Officer

Eugene P. Kennedy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eugene P. Kennedy Ownership Network

Ownership Network List of Eugene P. Kennedy

No Data

Ownership Network Relation of Eugene P. Kennedy


Eugene P. Kennedy Owned Company Details

What does Lumos Pharma Inc do?

Who are the key executives at Lumos Pharma Inc?

Eugene P. Kennedy is the Chief Medical Officer of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .

Lumos Pharma Inc (LUMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lumos Pharma Inc Insider Transactions

No Available Data

Eugene P. Kennedy Mailing Address

Above is the net worth, insider trading, and ownership report for Eugene P. Kennedy. You might contact Eugene P. Kennedy via mailing address: 2503 South Loop Drive, Ames Ia 50010.

Discussions on Eugene P. Kennedy

No discussions yet.